Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

BioCorRx (BICX) Other Gross PP&E Adjustments (2016 - 2025)

BioCorRx's Other Gross PP&E Adjustments history spans 15 years, with the latest figure at -$43186.0 for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments fell 205.03% year-over-year to -$43186.0; the TTM value through Sep 2025 reached -$43186.0, down 205.03%, while the annual FY2024 figure was -$4633.0, 104.76% down from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was -$43186.0 at BioCorRx, down from $14416.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $123893.0 in Q1 2024 and bottomed at -$269694.0 in Q1 2021.
  • The 5-year median for Other Gross PP&E Adjustments is -$43186.0 (2025), against an average of -$67824.9.
  • The largest annual shift saw Other Gross PP&E Adjustments skyrocketed 371.99% in 2024 before it crashed 205.03% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$190370.0 in 2021, then skyrocketed by 60.15% to -$75855.0 in 2022, then soared by 228.24% to $97273.0 in 2023, then plummeted by 104.76% to -$4633.0 in 2024, then crashed by 832.14% to -$43186.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Other Gross PP&E Adjustments are -$43186.0 (Q3 2025), $14416.0 (Q2 2025), and $4208.0 (Q1 2025).